个人中心 - 老虎社区

乐山大佛笑哈哈

IP属地：广东

帖子 · 275帖子 · 275
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-29 12:05
  $百大集团(600865)$ 诱多而已啦
  9 评论
  1
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-29 12:05
  $派格生物医药-B(02565)$ 当前派格生物市净率仅1.9倍，远低于港股生物科技板块平均3.2倍的市净率水平，即便考虑研发投入收缩，估值仍具备安全边际
  16 评论
  1
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-27
  $通合科技(300491)$ 今天够强的啦
  215 评论
  1
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-27
  $同源康医药-B(02410)$ 短期来看，ASCO数据公布、TY-9591获批都是明确的催化因素，长期来看，TY-9591上市后管线陆续推进，公司成长空间已经打开，具备较好的投资机会
  104 评论
  1
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-20
  $泰坦科技(688133)$ 放量了
  197 评论
  点赞
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-20
  $果下科技(02655)$ 卡位AI算力储能新赛道，公司不仅巩固了传统储能业务，更前瞻性布局AI算力中心储能这一新兴赛道
  407 评论
  点赞
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-20
  $拓璞数控(07688)$ 只能说你好野
  42 评论
  点赞
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-20
  $智谱(02513)$ GLM-5V-Turbo多模态模型在Design2Code基准中得分94.8，仍为全球开源模型第一
  358 评论
  点赞
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-18
  $新风光(688663)$ 明天过百是大概率事情
  351 评论
  1
  分享
  举报
- 乐山大佛笑哈哈乐山大佛笑哈哈
  ·05-18
  $中慧生物-B(02627)$ 公司2025年IPO募资剩余资金约1.28亿港元，且流感疫苗“慧尔康欣3”已实现商业化，短期运营资金压力较小。
  272 评论
  1
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4203843771083212","uuid":"4203843771083212","gmtCreate":1740740593407,"gmtModify":1740740666896,"name":"乐山大佛笑哈哈","pinyin":"lsdfxhhleshandafoxiaohaha","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":5,"tweetSize":275,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":569439664943248,"gmtCreate":1780027556436,"gmtModify":1780028675271,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/600865\">$百大集团(600865)$ </a> 诱多而已啦","listText":"<a href=\"https://laohu8.com/S/600865\">$百大集团(600865)$ </a> 诱多而已啦","text":"$百大集团(600865)$ 诱多而已啦","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569439664943248","isVote":1,"tweetType":1,"viewCount":9,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569439204451648,"gmtCreate":1780027527857,"gmtModify":1780028675112,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 当前派格生物市净率仅1.9倍，远低于港股生物科技板块平均3.2倍的市净率水平，即便考虑研发投入收缩，估值仍具备安全边际","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 当前派格生物市净率仅1.9倍，远低于港股生物科技板块平均3.2倍的市净率水平，即便考虑研发投入收缩，估值仍具备安全边际","text":"$派格生物医药-B(02565)$ 当前派格生物市净率仅1.9倍，远低于港股生物科技板块平均3.2倍的市净率水平，即便考虑研发投入收缩，估值仍具备安全边际","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569439204451648","isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":568812006728888,"gmtCreate":1779874402587,"gmtModify":1779874681229,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/300491\">$通合科技(300491)$ </a> 今天够强的啦","listText":"<a href=\"https://laohu8.com/S/300491\">$通合科技(300491)$ </a> 今天够强的啦","text":"$通合科技(300491)$ 今天够强的啦","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/568812006728888","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":568812225331544,"gmtCreate":1779874375832,"gmtModify":1779874670481,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 短期来看，ASCO数据公布、TY-9591获批都是明确的催化因素，长期来看，TY-9591上市后管线陆续推进，公司成长空间已经打开，具备较好的投资机会","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 短期来看，ASCO数据公布、TY-9591获批都是明确的催化因素，长期来看，TY-9591上市后管线陆续推进，公司成长空间已经打开，具备较好的投资机会","text":"$同源康医药-B(02410)$ 短期来看，ASCO数据公布、TY-9591获批都是明确的催化因素，长期来看，TY-9591上市后管线陆续推进，公司成长空间已经打开，具备较好的投资机会","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/568812225331544","isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566213582672680,"gmtCreate":1779270050400,"gmtModify":1779270052142,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/688133\">$泰坦科技(688133)$ </a> 放量了","listText":"<a href=\"https://laohu8.com/S/688133\">$泰坦科技(688133)$ </a> 放量了","text":"$泰坦科技(688133)$ 放量了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566213582672680","isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566213183690928,"gmtCreate":1779270034291,"gmtModify":1779270036683,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02655\">$果下科技(02655)$ </a> 卡位AI算力储能新赛道，公司不仅巩固了传统储能业务，更前瞻性布局AI算力中心储能这一新兴赛道","listText":"<a href=\"https://laohu8.com/S/02655\">$果下科技(02655)$ </a> 卡位AI算力储能新赛道，公司不仅巩固了传统储能业务，更前瞻性布局AI算力中心储能这一新兴赛道","text":"$果下科技(02655)$ 卡位AI算力储能新赛道，公司不仅巩固了传统储能业务，更前瞻性布局AI算力中心储能这一新兴赛道","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566213183690928","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566213028426696,"gmtCreate":1779269919261,"gmtModify":1779269921017,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/07688\">$拓璞数控(07688)$ </a> 只能说你好野","listText":"<a href=\"https://laohu8.com/S/07688\">$拓璞数控(07688)$ </a> 只能说你好野","text":"$拓璞数控(07688)$ 只能说你好野","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566213028426696","isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566212908168128,"gmtCreate":1779269889785,"gmtModify":1779269892066,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02513\">$智谱(02513)$ </a> GLM-5V-Turbo多模态模型在Design2Code基准中得分94.8，仍为全球开源模型第一","listText":"<a href=\"https://laohu8.com/S/02513\">$智谱(02513)$ </a> GLM-5V-Turbo多模态模型在Design2Code基准中得分94.8，仍为全球开源模型第一","text":"$智谱(02513)$ GLM-5V-Turbo多模态模型在Design2Code基准中得分94.8，仍为全球开源模型第一","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566212908168128","isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":565492886630528,"gmtCreate":1779094197329,"gmtModify":1779094199428,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/688663\">$新风光(688663)$ </a> 明天过百是大概率事情","listText":"<a href=\"https://laohu8.com/S/688663\">$新风光(688663)$ </a> 明天过百是大概率事情","text":"$新风光(688663)$ 明天过百是大概率事情","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/565492886630528","isVote":1,"tweetType":1,"viewCount":351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":565492760617040,"gmtCreate":1779094165930,"gmtModify":1779094168352,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4203843771083212","idStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 公司2025年IPO募资剩余资金约1.28亿港元，且流感疫苗“慧尔康欣3”已实现商业化，短期运营资金压力较小。","listText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 公司2025年IPO募资剩余资金约1.28亿港元，且流感疫苗“慧尔康欣3”已实现商业化，短期运营资金压力较小。","text":"$中慧生物-B(02627)$ 公司2025年IPO募资剩余资金约1.28亿港元，且流感疫苗“慧尔康欣3”已实现商业化，短期运营资金压力较小。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/565492760617040","isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}